Concepedia

Luus Wiegman

LW

Statistics

Publications

5

Citations

2.1K

H-Index

5

Active since

1999

Affiliations

Genmab (Netherlands)(Current)

University Medical Center Utrecht

Janssen (United States)

Springhouse

Luus Wiegman is an author at Genmab (Netherlands) specializing in antibody characterization, antibodies, and monoclonal antibodies.

Publications per year

1999–2021

5

Publications

5

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

Marijn van der Neut Kolfschoten, Janine Schuurman, Mario Losen et al. · Science · 2007 · 975 citations

, , +17

The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20

Jessica L. Teeling, Wendy J.M. Mackus, Luus Wiegman et al. · The Journal of Immunology · 2006 · 604 citations

, , +17

Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79

Jeroen Lammerts van Bueren, Danielle Jakobs, Niels Kaldenhoven et al. · Blood · 2014 · 221 citations

, , +16

Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET

Joost Neijssen, Rosa M. F. Cardoso, Kristen Chevalier et al. · Journal of Biological Chemistry · 2021 · 159 citations · Full text

, , +17

A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments

Gerwin Huls, Ingmar Heijnen, Maria Emanuela Cuomo et al. · Nature Biotechnology · 1999 · 96 citations

, , +16

1–5 of 5